In the DNA sequence flanking the 5' region of the human Insulin gene (U-and L-alleles) were studied in relation to atherosclerosis, lipid levels, and age In three groups of atherosclerotic Individuals and in nonatherosclerotlc controls. The atherosclerotic groups comprised a postmyocardlal infarction group with a mean age of 48 years, a group of Individuals operated on for carotid stenosis with a mean age of 62 years, and a group of 85-year-olds with clinical coronary disease, peripheral arterial disease, or both. All 331 individuals were unrelated Caucasians of Danish ancestry. There were no significant differences (p>0.05) In genotype distribution or allele frequencies between atherosclerotic and nonatherosclerotlc Individuals, but In the 85-year-olds, there was evidence (p<0.10) for a lower U-allele frequency in nonatherosclerotlc women compared to atherosclerotic women. In nonatherosclerotlc women, there was a significant decrease In U-allele frequency with age (60 to 85 years). This decrease does not prove conclusively, but Is compatible with, the hypothesis that the U-allele predisposes to, or the L-allele protects against, atherosclerosis. The possible effect of the U-allele on the development of atherosclerosis does not seem to be mediated through conventional risk factors. (Arteriosclerosis 10:372-378, May/June 1990)
Variations
In the DNA sequence flanking the 5' region of the human Insulin gene (U-and L-alleles) were studied in relation to atherosclerosis, lipid levels, and age In three groups of atherosclerotic Individuals and in nonatherosclerotlc controls. The atherosclerotic groups comprised a postmyocardlal infarction group with a mean age of 48 years, a group of Individuals operated on for carotid stenosis with a mean age of 62 years, and a group of 85-year-olds with clinical coronary disease, peripheral arterial disease, or both. All 331 individuals were unrelated Caucasians of Danish ancestry. There were no significant differences (p>0.05) In genotype distribution or allele frequencies between atherosclerotic and nonatherosclerotlc Individuals, but In the 85-year-olds, there was evidence (p<0.10) for a lower U-allele frequency in nonatherosclerotlc women compared to atherosclerotic women. In nonatherosclerotlc women, there was a significant decrease In U-allele frequency with age (60 to 85 years). This decrease does not prove conclusively, but Is compatible with, the hypothesis that the U-allele predisposes to, or the L-allele protects against, atherosclerosis. The possible effect of the U-allele on the development of atherosclerosis does not seem to be mediated through conventional risk factors. (Arteriosclerosis 10:372-378, May/June 1990) A highly polymorphic region flanks the 5' end of the human insulin gene on the short arm of chromosome 11. 1 -6 This region is located 363 base pairs (bp) upstream from the transcription start site of the gene and is due to variation in the number of repeats of a 14 bp oligonucleotide. 678 In Caucasians, there are two predominant size classes of insertions: a common, small L-allele (class 1 allele) with an average size of 570 bp and a large, less common U-aJlele (class 3 allele) with an average size of 2470 bp. 9 The L-and U-alleles are stable genetic elements and segregate in families according to Mendelian laws. 6 - 10 Owerbach et aJ. 1011 described an association in samples from the Danish population between the U-allele and atherosclerosis in diabetic as well as in nondiabetic individuals. This association was confirmed by MandrupPoulsen et al. 12 in nondiabetic Danish individuals undergoing coronary angiography. However, similar studies from the United Kingdom of individuals undergoing coronary angiography 13 and of postmyocardial infarction patients 14 did not support these findings.
In the present study, we have examined the possible association of the U-allele with atherosclerosis in further detail in three new and independent atherosclerotic samples from the Danish population: postmyocardial infarction patients, patients operated on for carotid stenosis, and a group of 85-year-olds with clinical coronary and/or peripheral arterial disease. Since the study was designed to identify three samples of different mean ages, we also studied the U-allele frequency as a function of age in nonatherosclerotic individuals.
Methods Subjects
Frequencies of U-and L-alleles were compared between atherosclerotic and nonatherosclerotic individuals in three samples of different mean ages from the Danish population. Individuals with familial hypercholesterolemia were excluded from the study, as were individuals with possible secondary dyslipidemias caused by liver disease, renal disease, gout, thyroid disease, primary hypercalcemia, or hormonal treatment. Individuals with diabetes or elevated fasting blood glucose (as defined in the legends to Tables 1, 2, and 3) excluded, but all statistical analyses were carried out both with and without these subjects included. All participants were unrelated Caucasians of Danish ancestry. They were studied after informed consent, and the experimental protocol was approved by ethics committees in Copenhagen and Arhus, Denmark.
In the first sample, the Myocardial Infarction (Ml) Study (Table 1) , 55 men younger than 55 years of age were recruited consecutively upon admission to a hospital with a first Ml. The nonatherosclerotic individuals comprised 45 men within the same age range as the patients, who were randomly selected via the Central Person Register (CPR), which reflects the person's date of birth and gender, from a surgical outpatient clinic at the same hospital. On re-examination, two patients were excluded because the diagnosis of Ml was uncertain, and three controls were excluded because of ischemia.
Atherosclerotic individuals in the second sample, the Carotid Study (Table 2) , were 58 men and 29 women operated on for uni-or bilateral carotid stenosis, who were consecutively selected from an outpatient clinic. Fifty-eight men and 29 women without atherosclerosis and within the same age range as the patients were randomly selected via the CPR from the Copenhagen City Heart Study.
1516 Four men and four women were excluded from the study because they had developed signs of ischemia since the last examination in [1981] [1982] [1983] .
The third sample, the 85-Year-Olds Study (Table 3) , comprised 70 85-year-old men and women from the Glostrup Population Study, 1718 who were originally selected in 1966 on the basis of year of birth and residence in Glostrup and eight neighboring municipalities (Copenhagen) . These individuals were divided into atherosclerotic and nonatherosclerotic groups on the basis of the following criteria: history of Ml, stroke, amputation due to arterial disease, angina pectoris, intermittent claudication, or signs of earlier Ml or ischemia on resting electrocardiogram (ECG).
The 85-yearold group was examined as described previously, 17 ' 18 and the principles were the same as in the two following studies. Individuals intended for the nonatherosclerotic groups in the Ml and Carotid Studies answered a modified Rose's cardiovascular questionnaire 19 and were interviewed by a physician and examined clinically (tests included a resting ECG). Criteria for the diagnosis of diabetes or elevated fasting blood glucose are stated in the legends to Tables 1 to 3 .
Laboratory Methods
In the study of 85-year-olds, blood sampling and biochemical analyses were performed as described previously.
1718 Low density lipoprotein (LDL) cholesterol was calculated using the Friedewald equation. 20 In the Ml and Carotid Studies, blood samples were drawn after a 12-hour fast and 3 months after the infarction in Ml patients. Very low density lipoprotein (VLDL) was isolated by tube slicing as the top fraction after ultracentrifugation of plasma at density 1.006 g/ml for 16 hours at 40 000 rpm and at 17°C in a Beckman 50.3 Ti rotor (Beckman Instruments, Palo Atto, CA). High density lipoprotein (HDL) cholesterol was measured in the supernatant after precipitation of apolipoprotein B-containing lipoproteins with dextran magnesium sulfate. 21 The cholesterol in LDL was calculated as plasma total cholesterol minus VLDL and HDL cholesterol. Cholesterol and triglycerides in plasma and in lipoprotein fractions were determined enzymatically (CHOD-PAP, GPO-PAP, Boehringer Mannheim, FRG). Apolipoproteins A-l, A-ll, and B were measured in whole plasma by endpoint turbidimetry with commercially available antisera and standards (Boehringer Mannheim and Immuno AG, Vienna, Austria). HbA^ was measured by ion-exchange chromatography. 22 ' 23 Fasting serum insulin was radioimmunologically determined. 24 
DNA Analysis
Total genomic DNA was prepared from the leukocytes of 10 ml of blood after lysis of red blood cells and was digested with either Bgll (85-Year-Olds Study) or Rsal and Sacl (double determinations, Ml and Carotid Studies) according to the manufacturer's specifications (Boehringer Mannheim). DNA fragments were separated according to size on 0.7% to 1.0% agarose gels (SeaKem ME, Interkemi, Denmark) and were transferred to nylon filters (Hybond-N, Amersham, Aylesbury, Buckinghamshire, UK) by Southern blotting. 25 The insulin gene probe (Ins-DO, Hagedorn Research Laboratory) was a Figure 1 . Organization of the insulin gene and the 5' hypervariable region. The diagram illustrates the location of restriction sites for the three enzymes used in this study and the relation of the insulin gene probe to these sites.
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groups and by gender. Statistical tests were carried out on the transformed values. The stepwise procedure (step-up method) for Fisher's linear discriminant analysis, 2829 a multivariate analysis, was applied to identify the independent set of discriminators between atherosclerotic and nonatherosclerotic groups in the three studies; genotypes were included in these analyses. The most parsimonious subset of predictors in each study was obtained by the ranking of variables whose t ratios were significant (Tables 1 to 3) . The x 2 test was used to compare genotype distribution and allele frequencies between atherosclerotic and nonatherosclerotic individuals in the three studies (Table 4) , as well as between atherosclerotic men and atherosclerotic women and between nonatherosclerotic men and nonatherosclerotic women within the studies. Differences in genotype distribution and allele frequencies between hypertriglyceridemic and normotriglyceridemic individuals within each study and differences in U-allele frequency as a function of age in 48-, 62-, and 85-year-old nonatherosclerotic individuals were also determined by the x 2 test.
One-way analysis of variance was performed on lipid and lipoprotein levels as well as on other continuous variables to test the null hypothesis that phenotypic variation is not associated with genetic variation at the hypervariable 5' locus. 
Results
Size variations within L-alleles (class 1 alleles) and U-alleles (class 3 alleles) were slight, and no class 2 alleles 9 (alleles of an intermediate size class of 1320 bp)
were found in any of the individuals studied. This is in accordance with earlier reports that class 2 alleles occur in less than 1 % of Caucasians.
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Study Populations
The clinical and biochemical characteristics of atherosclerotic and nonatherosclerotic groups in the three studies are shown in Tables 1 to 3 , as are the ranked significant independent discriminators between these groups.
1.6 kb genomic insulin gene fragment (Figures 1 and 2) . The probe was labeled with deoxycytidine 5'-a-32 Ptriphosphate in aqueous solution (a-32 P-dCTP, 10 mCi/ml, specific activity 3000 Ci/mmol, Amersham) by nick translation 26 or by oligolabeling. 27 Filters were hybridized at a concentration of 1 to 2x10 6 cpm/ml hybridization buffer.
Statistical Analysis
Statistical analysis of the data was carried out by using MINITAB computer programs (Minitab, State College, PA). We considered statistical significance to be at the 0.05 level. Because of skewness, triglycerides and VLDL triglycerides were logarithmically transformed in all three studies, and fasting insulin was transformed to the negative reciprocal. Transformations were done within
Insulin Gene Polymorphism in Atherosclerotic and Nonatherosclerotic Individuals
The observed genotypes and relative allele frequencies of the insulin gene polymorphism are summarized in Table 4 . Since this polymorphism has been associated with diabetes, 31 data are given for all individuals combined and for groups from which diabetics and subjects with elevated fasting blood glucose were excluded. There were no significant differences (p>0.05) in genotype distribution or allele frequencies between atherosclerotic and nonatherosclerotic men or women in any of the three studies. However, in the study of 85-year-olds, there was evidence (p<0.10) of a lower U-allele frequency in nonatherosclerotic women when compared to atherosclerotic women. Jowett et al. 32 ' 33 reported an association between hypertriglyceridemia (>2 mmol/l) and the U-allele. We found no significant differences in genotype distribution or allele frequencies when hypertriglyceridemic groups were compared with normotriglyceridemic groups within each study (data not shown). 
Insulin Gene Polymorphism in Nonatherosclerotic Persons as Function of Age
There was a significant decrease in U-allele frequency with age in nonatherosclerotic women (p<0.025; no women in the Ml study) (Figure 3 ). The same trend was seen in men, but the decrease in U-allele frequency appeared at an earlier age and was not significant.
Insulin Gene Polymorphism and Upid Levels
Mean levels of plasma triglycerides, VLDL triglycerides, plasma cholesterol, VLDL cholesterol, LDL cholesterol, HDL cholesterol, ratio of LDL cholesterol to HDL cholesterol, and apolipoproteins B, A-l, and A-ll for the different genotypes (UU, UL, LL) were compared within the atherosclerotic and the nonatherosclerotic groups. Phenotypic variation in these variables was not associated with variation at the hypervariable 5' locus in any of the three studies (data not shown).
Insulin Gene Polymorphism and Other Biochemical and Clinical Characteristics
Phenotypic variation in body mass index (BMI), systolic and diastolic blood pressure, fasting blood glucose, fasting serum insulin, or HbAic 34 was not associated with genotypic variation at the 5' hypervariable locus in atherosclerotic or nonatherosclerotic groups in any of the three studies (data not shown).
Discussion
Denmark is a small racially and genetically homogeneous countryM.M compared to the United States or the United Kingdom and is thus well suited for populationbased genetic studies. The samples examined in the present study included only unrelated Caucasians of Danish ancestry.
Conventional Cardiovascular Risk Factors
That VLDL triglycerides were independent discriminators for Ml (Table 1 ) seems in agreement with the common finding in case-control studies of raised plasma triglycerides in Ml survivors. 37 However, in the majority of these studies, multjvariate analysis was not performed, and no adjustment for HDL cholesterol was made. In a recent Swedish case-control study of young male survivors of myocardial infarction, 38 which was larger but otherwise similar to our Ml Study, the best set of independent lipoprotein and apolipoprotein discriminators selected by stepwise multiple discriminant analysis were LDL cholesterol, HDL cholesterol, serum triglycerides, and by guest on November 8, 2017 http://atvb.ahajournals.org/ Downloaded from VLDL cholesterol (VLDL trigtycerides were not included in this model). This agrees with our findings, when taking into account that most of the fasting serum triglycerides are in VLDL, and that apolipoprotein A-l has been shown to be superior to HDL cholesterol in identifying patients with coronary artery disease. 39 It is unclear why LDL cholesterol was not an independent predictor in our Ml Study.
Age and hypertension history are the most important risk factors for symptomatic cerebrovascular disease and have emerged as risk factors for cerebrovascular atherosclerosis. 40 An inverse relation of HDL cholesterol to carotid atherosclerosis has also been demonstrated, 41 whereas considerable controversy exists regarding the relation of cholesterol and LDL cholesterol to cerebrovascular disease. 4041 In agreement with these results, diastolic blood pressure was found to be an important discriminator between patients and controls in both men and women in the carotid study ( Table 2) . Plasma cholesterol in men and apolipoprotein A-l in women were also independent discriminators. Why plasma glucose is inversely related to carotid atherosclerosis in women is not clear. It may reflect the higher insulin levels in the patients, since hyperinsulinemia has been shown in some studies to be an independent risk factor at least for coronary atherosclerosis. 42 Established major cardiovascular risk factors apply in the elderty as in the young, but with less impact. 43 In 85-year-old men, none of the variables discriminated between patients and controls (Table 3) , presumably because of the small sample size. HDL cholesterol was the only significant discriminator in 85-year-old women (Table 3) ; genotype was the second most important, although not statistically significant (data not shown).
Smoking is still very prevalent in the Danish population. In none of the three studies were there any significant differences (p>0.05, \ 2 test) between percentage smokers, ex-smokers, or non-smokers in cases and controls. This probably explains why smoking classified in this rather crude manner cannot discriminate between patients and controls on multjvariate analysis in any of these studies.
Insulin Gene Polymorphism
Three previous studies in Danes have reported a higher frequency of the U-allele in atherosclerotic compared with nonatherosclerotic individuals, 101112 mainly due to a significant difference in U-allele frequency between atherosclerotic and nonatherosclerotic women. This is in accordance with our finding in the 85-year-old women, but we were unable to repeat this finding in 62-year-old women with or without carotid stenosis. However, our data suggest ( Table 2 ) that well-known risk factors for atherosclerosis are the best discriminators between the two groups of women in the Carotid Study and may thus mask the effect of U/L genotype. A similar explanation seems plausible for the fact that an effect of U/L genotype has been difficult to demonstrate in men or in mixed studies where men and women were not analyzed separately: in the present and previous studies in Danes, 1011 ' 12 in studies from the UK, 1314 and in studies from Finland. 44 The explanation for this apparent gender difference could be that men are under the strongest selection from well-known risk factors for atherosclerosis, which in the present and former studies 12 have been shown not to be associated with U/L genotype.
A major finding of the present study is a significant decrease in U-allele frequency with age in clinically nonatherosclerotic women, all from the Copenhagen area. This suggests that female U-allele carriers are more likely to die than L-allele carriers from atherosclerosis or other causes associated with the U-allele or that U-allele carriers become atherosclerotic. The U-allele frequency also seems to decrease with age in the Danish population as a whole, including both atherosclerotic and nonatherosclerotic individuals. 31 This would suggest that U-allele earners die at an earlier age than L-allele earners but cannot state anything about the cause of this.
Most likely, the polymorphic region is a weak genetic marker for atherosclerosis through linkage disequilibrium with an atherosclerosis predisposing gene. An obvious candidate gene would be the insulin-like growth factor II (IGF II) gene, which is tightly linked to the insulin gene. 4548 IGF II is not known to be involved in the etiology of atherosclerosis, but the apparent importance of IGF II for growth and maintenance of cells and the occurrence of variant IGF II polypeptides to which cells may respond in an abnormal fashion might also apply to cells in the vessel wall.
In conclusion, the present study does not prove conclusively, but is compatible with, the hypothesis that the U-allele predisposes to, or the L-allele protects against, atherosclerosis and that this effect is seen most clearly in women. Furthermore, the possible effect of the U-allele on the development of atherosclerosis does not seem to be mediated through conventional risk factors.
